Pharmaceuticals in Russia

Date: November 21, 2012
Pages: 37
Price:
US$ 350.00
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PE5AB30CEE9EN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in Russia
INTRODUCTION

Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Russia pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

HIGHLIGHTS
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The Russian pharmaceuticals market had total revenues of $14.8 billion in 2011, representing a compound annual growth rate (CAGR) of 16.1% between 2007 and 2011.
  • The performance of the market is forecast to decelerate, with an anticipated CAGR of 11% for the five-year period 2011 - 2016, which is expected to drive the market to a value of $24.9 billion by the end of 2016.
FEATURES
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Russia
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Russia
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Russia pharmaceuticals market with five year forecasts
  • Macroeconomic indicators provide insight into general trends within the Russia economy
KEY QUESTIONS ANSWERED
  • What was the size of the Russia pharmaceuticals market by value in 2011?
  • What will be the size of the Russia pharmaceuticals market in 2016?
  • What factors are affecting the strength of competition in the Russia pharmaceuticals market?
  • How has the market performed over the last five years?
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Pharmstandard OJSC
Sanofi
Novartis AG
Bayer AG
Macroeconomic Indicators
Country Data
Appendix
Methodology
Industry associations
Related MarketLine research

LIST OF TABLES

Table 1: Russia pharmaceuticals market value: $ billion, 2007–11
Table 2: Russia pharmaceuticals market geography segmentation: $ billion, 2011
Table 3: Russia pharmaceuticals market share: % share, by value, 2011
Table 4: Russia pharmaceuticals market value forecast: $ billion, 2011–16
Table 5: Pharmstandard OJSC: key facts
Table 6: Pharmstandard OJSC: key financials ($)
Table 7: Pharmstandard OJSC: key financials (RUB)
Table 8: Pharmstandard OJSC: key financial ratios
Table 9: Sanofi: key facts
Table 10: Sanofi: key financials ($)
Table 11: Sanofi: key financials (€)
Table 12: Sanofi: key financial ratios
Table 13: Novartis AG: key facts
Table 14: Novartis AG: key financials ($)
Table 15: Novartis AG: key financial ratios
Table 16: Bayer AG: key facts
Table 17: Bayer AG: key financials ($)
Table 18: Bayer AG: key financials (€)
Table 19: Bayer AG: key financial ratios
Table 20: Russia size of population (million), 2007–11
Table 21: Russia gdp (constant 2000 prices, $ billion), 2007–11
Table 22: Russia gdp (current prices, $ billion), 2007–11
Table 23: Russia inflation, 2007–11
Table 24: Russia consumer price index (absolute), 2007–11
Table 25: Russia exchange rate, 2007–11

LIST OF FIGURES

Figure 1: Russia pharmaceuticals market value: $ billion, 2007–11
Figure 2: Russia pharmaceuticals market geography segmentation: % share, by value, 2011
Figure 3: Russia pharmaceuticals market share: % share, by value, 2011
Figure 4: Russia pharmaceuticals market value forecast: $ billion, 2011–16
Figure 5: Forces driving competition in the pharmaceuticals market in Russia, 2011
Figure 6: Drivers of buyer power in the pharmaceuticals market in Russia, 2011
Figure 7: Drivers of supplier power in the pharmaceuticals market in Russia, 2011
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2011
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2011
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2011
Figure 11: Pharmstandard OJSC: revenues & profitability
Figure 12: Pharmstandard OJSC: assets & liabilities
Figure 13: Sanofi: revenues & profitability
Figure 14: Sanofi: assets & liabilities
Figure 15: Novartis AG: revenues & profitability
Figure 16: Novartis AG: assets & liabilities
Figure 17: Bayer AG: revenues & profitability
Figure 18: Bayer AG: assets & liabilities
OTC Pharmaceuticals in Russia US$ 350.00 Aug, 2013 · 33 pages
The Pharmaceutical Market: Russia US$ 1,295.00 Jan, 2013 · 97 pages

Ask Your Question

Pharmaceuticals in Russia
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: